about
Lipid raft-targeted therapy in multiple myeloma.Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice.Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy.Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected miceA simple approach to obtain hybrid Au-loaded polymeric nanoparticles with a tunable metal loadLipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections.Vascular endothelial growth factor-delivery systems for cardiac repair: an overview.Brain drug delivery systems for neurodegenerative disorders.Diagnostic and therapeutic uses of nanomaterials in the brain.Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.Heart regeneration after myocardial infarction using synthetic biomaterials.Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy.Brain aging and Parkinson's disease: New therapeutic approaches using drug delivery systems.Reformulating cyclosporine A (CsA): More than just a life cycle management strategy.Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein.Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys.Clinical advances of nanocarrier-based cancer therapy and diagnostics.Edelfosine lipid nanoparticles overcome multidrug resistance in K-562 leukemia cells by a caspase-independent mechanism.Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges.Hydrogel based approaches for cardiac tissue engineering.PEGylated-PLGA microparticles containing VEGF for long term drug delivery.Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin.In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres.Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor.Nanocarriers with gentamicin to treat intracellular pathogens.Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis.Optimization of topical cidofovir penetration using microparticles.Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion.In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity.Efficacy of edelfosine lipid nanoparticles in breast cancer cells.Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.Development and validation of a liquid chromatographic method for in vitro mupirocin quantification in both skin layers and percutaneous penetration studies.High-performance liquid-chromatographic determination of rifampicin in plasma and tissues.Rapid and simple determination of doxycycline in serum by high-performance liquid chromatography. Application to particulate drug delivery systems.Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
P50
Q34112080-A28EF77C-8D30-4FC6-A678-575F6F464A0FQ34935395-648EE0F3-853C-4C8F-A625-B9738201D17EQ35107994-6A64F0A3-D47E-4F86-9E29-AFEF7920758BQ35758804-E719474C-EB9D-4892-869B-7512A2299E5AQ35854292-5B783F37-AFA6-4E5E-A605-F56A284D403EQ36208560-80EC1B2F-403F-439E-A8DE-FB237A980AEEQ36969831-F4A6C1DC-6122-473A-8A02-049ECF7B2CCFQ36985919-DAF84579-EE37-4770-8FB1-EEAA6911B7D5Q38022017-54B75F37-538C-4D4A-B0EF-239673189E81Q38046929-B4F21549-61E3-4D03-A0EF-9007D0BA1519Q38241471-4B427AA8-6DAB-4082-9942-5F3FC7DDB798Q38327984-0C4E150A-FE57-44C6-828E-DE2A37F66F25Q38349515-59EB2BBD-C3C9-4EB1-BE2C-8A8130212CD5Q38616717-F0D1B45F-9C62-4664-B9B3-2BA6F1DDBC07Q38665187-5633400D-A978-4014-8407-1DF4F9A79EB7Q38717568-4D2D1386-CF3A-4F96-A6A1-1EE347F82F7CQ38730277-00142F6B-D880-44D0-81A1-AA500B32E748Q38742695-567A8ED6-C3F8-48DD-A5F2-25B0DF3738A9Q38848965-3B2E559D-1475-4C9D-B3C9-34B137511157Q38991184-4A8B9DF2-0FFE-4DD9-8526-D48BE263623DQ39020937-E50315EF-6C89-4F38-A7C4-6BB0771A447BQ39042772-B885D50C-DA67-452E-8B5A-ED43857DE7E6Q39311713-A926A633-A928-487F-953F-4F39DDD84EFAQ39344545-706AD068-1865-4BFE-8CB8-6FE76D0D3714Q39494188-EECE39CA-C317-4814-A2A8-801691C78751Q39991344-964C4DF1-1645-4E1D-B654-F02E88B03652Q40133406-85B09722-89D1-463B-B323-837CB4E078B2Q40218706-AEA90E45-D76A-41E2-92C9-7B42EE99B29BQ40710906-795BC2CA-3B00-48B2-9299-5F2513844A21Q42524786-CF0C8E5B-9479-49C8-AF9F-9FC776CF49C1Q42564834-241841B6-5A72-4456-A91C-C81359A7531FQ43127276-2C4318BF-94B5-4571-AFF1-7F7AC7B77EE9Q44320317-B9B160ED-5EEB-4765-BCB9-E8289F964265Q44442151-1E0321D6-25E8-4A88-A1CB-1F38E79DC672Q44543727-A7C375E4-1F2D-467A-B487-A132F8B704F9Q44633662-D4E17C91-C64A-40F5-B411-DD9849F818E1Q44825792-56AAAA91-FB1F-4256-AD57-C310A46A4C19Q44825795-A5C58D73-1698-4B29-B520-C628577815A0Q44878999-81338A3F-58B8-4941-830D-31875CD2D424Q45323473-720CC773-EE4B-4FBD-A0D2-CE198FC016A3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
María J Blanco-Prieto
@ast
María J Blanco-Prieto
@en
María J Blanco-Prieto
@es
María J Blanco-Prieto
@nl
type
label
María J Blanco-Prieto
@ast
María J Blanco-Prieto
@en
María J Blanco-Prieto
@es
María J Blanco-Prieto
@nl
altLabel
Maria J Blanco-prieto
@en
prefLabel
María J Blanco-Prieto
@ast
María J Blanco-Prieto
@en
María J Blanco-Prieto
@es
María J Blanco-Prieto
@nl
P1053
E-6665-2017
P106
P21
P31
P496
0000-0003-0710-899X